HYDRALAZINE HCL VOLUNTARY RECALL DUE TO PARTICULATES

Luitpold Pharmaceuticals, Inc. and the FDA notified healthcare professionals of a voluntary recall of additional lots of Hydralazine HCl Injection (20 mg/mL, 1 mL single dose vials) because the products may contain particulates. This comes on the heels of a voluntary recall posted on August 3, 2006, notifying of some vials of Hydralazine HCL Injection from lot number 5561 NO with an expiration date of December, 2006 (20 mg/mL, 1 mL single dose vials), which may contain particulates.

()a href="http://www.docguide.com/news/content.nsf/news/852571020057CCF6852571D80051BBD2" target="_blank">DG News